Skip to main content

Logo (Actavis) 3117 Logo (Actavis) 3117 Pill - brown capsule/oblong, 20mm

Pill with imprint Logo (Actavis) 3117 Logo (Actavis) 3117 is Brown, Capsule/Oblong and has been identified as Morphine Sulfate Extended-Release 75 mg. It is supplied by Actavis Elizabeth LLC.

Morphine is used in the treatment of Chronic Pain; Neonatal Abstinence Syndrome; Pain and belongs to the drug class Opioids (narcotic analgesics). Risk cannot be ruled out during pregnancy. Morphine 75 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for Logo (Actavis) 3117 Logo (Actavis) 3117

Morphine sulfate extended-release 75 mg Logo (Actavis) 3117 Logo (Actavis) 3117
Morphine sulfate extended-release 75 mg Logo (Actavis) 3117 Logo (Actavis) 3117

Morphine Sulfate Extended-Release

Logo (Actavis) 3117 Logo (Actavis) 3117
75 mg
20.00 mm
Prescription only
Drug Class
Opioids (narcotic analgesics)
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
2 - High potential for abuse
Labeler / Supplier
Actavis Elizabeth LLC
National Drug Code (NDC)
Inactive Ingredients
diethyl phthalate, ethylcellulose, gelatin, methacrylic acid - methyl methacrylate copolymer (1:1), polyethylene glycol, sucrose, magnesium silicate, titanium dioxide, ferrosoferric oxide, ferric oxide red, ferric oxide yellow, butyl alcohol, alcohol, isopropyl alcohol, potassium hydroxide, propylene glycol, water, shellac, ammonia

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.